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Introduction
Eustachian tube dysfunction is very common and is the
predominant cause of otitis media with effusion. Nega-
tive middle ear pressure generated by Eustachian tube
dysfunction can cause deformation of the collagen layer
in the ear drum. Collagen becomes stretched and looses
its orderly array. Over time, deep retraction pockets
form. If left untreated, the tympanic membrane becomes
prone to cholesteatoma formation. CO2 laser energy
interacts with collagen and causes it to return to its
natural configuration.
Objective
To describe and review our results treating tympanic
membrane retraction pockets using laser myringoplasty
with a novel hand-held flexible photonic band gap fiber
CO2 laser.
Methods
A hand-held flexible fiber CO2 laser system (Omniguide
BeamPath) was used to treat tympanic membrane
retraction pockets. The fiber tip was held approximately
3mm from the membrane surface producing a spot size
of 570 microns at the setting of 2 watt per 100 millise-
cond pulse. Pulses were administered until the desired
level of membrane contraction was achieved. A tympa-
nostomy tube was then placed in the affected ear.
Results
We reviewed our results with this procedure on 22
patients (40 ears). The average pre-operative air bone gap
(ABG) pure-tone average (PTA) was 15 dB. The average
post-operative ABG PTA was 6 dB (p=0.002). All patients
had satisfactory contraction of the atelectatic segment.
There were no adverse events recorded.
Conclusion
Laser myringoplasty using the Omniguide hand-held
flexible fiber CO2 laser provides immediate hearing
improvement and eardrum contraction. Long-term
results are pending.
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